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方法：50 只英国种短毛雌性豚鼠，随机选择 42 只作为实验组，8 只作为对
照组。实验组单次腹腔注射链脲佐菌素（STZ），对照组注射相应剂量的枸橼酸




偿及失代偿不同表现。利用免疫组织化学 Maxvision 法检测 Smoothelin 在不同膀
胱结构如肌层、粘膜肌层以及血管的表达强度变化。通过蛋白质印迹法以及电泳
ECL 显色并应用凝胶成像系统对曝光图片上的蛋白条带灰度值进行采集与分析，
目的蛋白 Smoothelin 表达量以内参 β-actin 进行标准化，对比分析各实验组间蛋
白表达的差异情况。 
结果：经尾静脉血检测血糖后筛选入组模型 20 只（随机血糖大于
16.8mmol/L），糖尿病模型成功率 47.6％(20/42)。与对照组 8 只比较，观察糖尿
病组豚鼠体重（280.30±7.08）g，较对照组（351.50±10.07）g 显著下降（P＜0.01），
并伴有多尿、体重减轻、活动减少等阳性临床症状。经尿动力学检测成功 18 只
（喂养死亡 2 例），依据 DCP 判断标准，9 周时的 9 只糖尿病豚鼠中 6 只膀胱功
能代偿，3 只功能失代偿( 33.3% )；而在 12 周时的 9 只糖尿病豚鼠中，只有 1
只膀胱功能代偿，8 只功能失代偿（88.9% ）；对照组实验终点余 6 只膀胱功能























































































Objective To investigate the expression of Smoothelin in urinary bladder of 
streptozotocin-induced diabetic guinea pigs and the possible mechanisms of diabetic 
cystopathy.  
Methods Fifty female guinea pigs were randomly divided into STZ-induced 
diabetic（42） and normal control（8）. Urodynamic study was to evaluate the changes 
of bladder functionand and distinguish the diabetic cystopathy group among others. 
Immunohistochemistry and Western blot were used to detect the alteration of the 
expression of Smoothelin in diabetic bladder of guinea pigs within 9 and 12 weeks. 
Immunoreactivity of different bladder tissues also were observed. The expression 
amounts of Smoothelin were standardized by beta-actin. 
Results  Being detected by urodynamic of 18 successful STZ-induced diabetic 
models, the bladder capacity and residual urine were augmented, but the detrusor leak 
point pressure was increased in compensated stage(16.57±0.48 cmH2O) and then 
decreased significantly in decompensated stage(6.46±0.51 cmH2O) of diabetic guinea 
pigs(DCP) while the pressure of the controls was regarded as normal（15.29±1.38 
cmH2O）. With the same changes, the expression intensity and levels of Smoothelin 
were rose early and reduced lately in diabetic animals while compared with 
age-matched normal controls. Furthermore, according to the results of 
immunohistochemisty, immunostaining of muscularis mucosa in compensated and 
decompensated groups were weaker than the controls whereas the presentations of 
blood vessels were similar in three different groups. In contrast to the Smoothelin 
expressional level of the controls（3.755±0.128），the Smoothelin efficiency was 
significantly up-regulated in compensated group （4.585±0.0502）but decreased 
sharply in decompensated group（1.730±0.183）. on the other hand, compared to the 
clearly changes of Smoothelin expression, the expression level of beta-actin were not 
different among these groups. 
 Conclusions  Smoothelin is clearly related to myogenic dysfunction of 
diabetic cystopathy with the contribution for the contractility of detrusor and useful to 
















Smoothelin may play a important role at the modulation of SMC phenotypes. 
Maintaining contractile phenotypes of detrusor SMCs would be a useful pathway to 
prevent and treat the disease of diabetic cystopathy. 
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Smoothelin antibody MAB3242, Millipore, Billerica 
β-actin Sigma 
蛋白 Marker Fermentas 
蛋白酶抑制剂混合物 Amersham 
脱脂奶粉 完达山 
Quick Start Bradford Dye Reagent Bio-Rad, Hercules, CA 
增强化学发光 ECL Thermo 
羊抗鼠二抗 Thermo 
PVDF 膜 Millpore, Billerica 
其他化学纯和分析纯试剂 Sigma 
PBS 溶液 福州迈新生物技术开发公司 
酶标羊抗鼠抗 IgG 聚合物 福州迈新生物技术开发公司 
即用型免疫组化试剂盒 福州迈新生物技术开发公司 
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